Skip to main content

Find Clinical Trials

Home
Conditions
Blasts 10-19 Percent of Bone Marrow Nucleated Cells

Clinical trial condition

Blasts 10-19 Percent of Bone Marrow Nucleated Cells

Explore clinical trials studying Blasts 10-19 Percent of Bone Marrow Nucleated Cells. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Blasts 10-19 Percent of Bone Marrow Nucleated Cells trial results

Recruiting

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT03896269

Conditions: Blasts 10-19 Percent of Bone Marrow Nucleated Cells, Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Bone Marrow Diseases, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details